Imatinib Mesylate Tablets 400 mg recalled over manufacturing violations
- Recall date
- December 8, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Shilpa Medicare Limited recalls Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distribute…
- Recall number
- D-0125-2021
- FDA classification
- Class II
- Brand / firm
- Shilpa Medicare Limited
- Sold / distributed
- Nationwide in the U.S.
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-203-30.
Get recall alerts
Free email alert whenever Shilpa Medicare Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Shilpa Medicare Limited